Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
AesthetiCare is a specialized dermatology and aesthetic medicine company based in the United Kingdom, operating as a key division of Ferndale Pharmaceuticals. The company focuses on providing advanced, evidence-based skincare solutions and medical devices to aesthetic professionals and their patients. Their portfolio features globally recognized brands such as Heliocare, which utilizes Fernblock technology for comprehensive photo-protection, and Endocare, which employs growth factor technology for dermal regeneration. AesthetiCare is distinguished by its commitment to clinical efficacy, offering products that address a wide range of indications including skin aging, acne, and hyperpigmentation. In addition to product distribution, the company provides extensive clinical training and business support to practitioners within the medical aesthetic industry.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on AesthetiCare.